MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway

Breast cancer (BC) is the most common malignancy among women. Mesenteric estrogen-dependent adipogenesis gene (MEDAG) was first reported as a novel adipogenic gene, and its involvement and mechanism in visceral adiposity were analyzed. However, the role of MEDAG in BC is unclear. The biological role...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiyu, Li, Chenyuan, Wu, Qi, Tu, Yi, Wang, Changhua, Yu, Xin, Li, Bei, Wang, Zhong, Sun, Si, Sun, Shengrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814033/
https://www.ncbi.nlm.nih.gov/pubmed/33462219
http://dx.doi.org/10.1038/s41419-020-03340-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814033/
https://www.ncbi.nlm.nih.gov/pubmed/33462219
http://dx.doi.org/10.1038/s41419-020-03340-w

Ejemplares similares